Article
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
30 Sept 2022
Abstract excerpt
BACKGROUND: Prostate cancer is a clinically heterogeneous disease with a subset of patients rapidly progressing to lethal-metastatic prostate cancer. Current clinicopathological measures are imperfect predictors of disease progression. Epigenetic changes are amongst the earliest molecular changes in tumourigenesis. To find new prognostic biomarkers to enable earlier intervention and improved outcomes, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
